ArticleOncoimmunology
Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.
Valérie Dutoit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
trialcites it